Sagimet Biosciences Inc
NASDAQ:SGMT

Watchlist Manager
Sagimet Biosciences Inc Logo
Sagimet Biosciences Inc
NASDAQ:SGMT
Watchlist
Price: 5.59 USD -7.14% Market Closed
Market Cap: 169.9m USD
Have any thoughts about
Sagimet Biosciences Inc?
Write Note

Sagimet Biosciences Inc
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Sagimet Biosciences Inc
Cash from Financing Activities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Sagimet Biosciences Inc
NASDAQ:SGMT
Cash from Financing Activities
$86.2m
CAGR 3-Years
8%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Cash from Financing Activities
-$2.8B
CAGR 3-Years
45%
CAGR 5-Years
25%
CAGR 10-Years
1%
Gilead Sciences Inc
NASDAQ:GILD
Cash from Financing Activities
-$6.8B
CAGR 3-Years
0%
CAGR 5-Years
4%
CAGR 10-Years
-3%
Amgen Inc
NASDAQ:AMGN
Cash from Financing Activities
-$5.3B
CAGR 3-Years
0%
CAGR 5-Years
21%
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Cash from Financing Activities
-$1B
CAGR 3-Years
8%
CAGR 5-Years
-49%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Cash from Financing Activities
-$1.5B
CAGR 3-Years
-55%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Sagimet Biosciences Inc's Cash from Financing Activities?
Cash from Financing Activities
86.2m USD

Based on the financial report for Dec 31, 2023, Sagimet Biosciences Inc's Cash from Financing Activities amounts to 86.2m USD.

What is Sagimet Biosciences Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 3Y
8%

The average annual Cash from Financing Activities growth rates for Sagimet Biosciences Inc have been 8% over the past three years .

Back to Top